Esperion Therapeutics (ESPR) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on August 5, might help the stock move higher if these key numbers are better than e ...

核心观点 - 市场预期fuboTV在2025年第二季度将实现同比扭亏为盈 但营收预计下降 实际业绩与预期对比将影响股价短期走势 [1][2] - 公司盈利预期修正趋势显示分析师近期转向悲观 结合Zacks排名第三 难以预测其能否超预期盈利 [4][12] - 行业对比显示Roku更可能实现盈利超预期 因其盈利ESP为正值且Zacks排名更高 [19][20] 财务预期 - 预计季度每股亏损0.00美元 同比改善100% 营收预期3.5445亿美元 同比下降8.9% [3] - 最准确预估低于共识预期 导致盈利ESP为-800.01% 显示分析师近期转向悲观 [12] - 过去四个季度公司均超预期盈利 最近季度实际亏损0.02美元 较预期亏损0.04美元实现50%正意外 [13][14] 行业对比 - 同业公司Roku预计季度每股亏损0.16美元 同比改善33.3% 营收预期10.7亿美元 同比增长10.8% [18][19] - Roku盈利ESP为+7.41% 结合Zacks买入排名 更可能超预期盈利 且过去四个季度均超预期 [19][20] - Roku的共识EPS预估在过去30天上调3.1% 反映分析师乐观情绪 [19] 预测模型分析 - Zacks盈利ESP模型通过对比最准确预估与共识预估值 预测实际盈利偏离程度 [7][8] - 正盈利ESP结合Zacks排名前三时 预测准确率近70% 但负值不具备预测意义 [9][10][11] - 盈利超预期并非股价变动唯一因素 其他催化剂可能抵消盈利不及预期的影响 [15][16]

Zacks Consensus Estimate This natural gas producer is expected to post quarterly earnings of $5.03 per share in its upcoming report, which represents a year-over-year change of +72.9%. Revenues are expected to be $334.57 million, up 84.7% from the year-ago quarter. Estimate Revisions Trend Gulfport Energy (GPOR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the ...

The market expects Green Plains Renewable Energy (GPRE) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The earnings report might help the stock move higher if these key numbers are better than expectations. On the othe ...

The market expects Hamilton Lane (HLNE) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on August 5, might help the stock move higher if these key numbers are better ...

The market expects Harmony Biosciences Holdings, Inc. (HRMY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on August 5, might help the stock move higher if these ...

Henry Schein (HSIC) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on August 5, might help the stock move higher if these key numbers are better than expectati ...

Wall Street expects a year-over-year decline in earnings on higher revenues when J&J Snack Foods (JJSF) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 5. ...

The market expects Karyopharm Therapeutics (KPTI) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, ...

This an electric vehicle automaker is expected to post quarterly loss of $0.22 per share in its upcoming report, which represents a year-over-year change of +24.1%. Lucid Group (LCID) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near ...